QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study

There is no fulltext present in this item.

Title:	QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study
Author(s):	Guglielmetti, L.; Tiberi, S.; Burman, M.; Kunst, H.; Wejse, C.; Togonidze, T.; Ingen, J. van ; Magis-Escurra, C. ; Bothamley, G.; Lange, C de
Publication year:	2018
Source:	European Respiratory Journal, vol. 52, iss. 2, (2018), article pii: 1800537
ISSN:	0903-1936
DOI:	https://doi.org/10.1183/13993003.00537-2018
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/196927
Display more details
Subject:	Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences
Organization:	Medical Microbiology Pulmonary Diseases
Journal title:	European Respiratory Journal
Volume:	vol. 52
Issue:	iss. 2
Article number:	pii: 1800537